CompletedPhase 1NCT00636285
Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants
Studying Staphylococcal toxemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Biosynexus Incorporated
- Principal Investigator
- Leonard Weisman, MDBaylor College of Medicine
- Intervention
- Placebo(drug)
- Enrollment
- 8 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2001 – 2001
Study locations (1)
- Baylor College of Medicine, Houston, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00636285 on ClinicalTrials.govOther trials for Staphylococcal toxemia
Additional recruiting or active studies for the same condition.